These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 8983642)

  • 21. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H; Hayashi K; Saruta T
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
    Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
    J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
    Benigni A; Gagliardini E; Remuzzi A; Corna D; Remuzzi G
    Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
    Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
    J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.
    Falk RJ; Scheinman J; Phillips G; Orringer E; Johnson A; Jennette JC
    N Engl J Med; 1992 Apr; 326(14):910-5. PubMed ID: 1542341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content.
    Bertani T; Zoja C; Abbate M; Rossini M; Remuzzi G
    Lab Invest; 1989 Feb; 60(2):196-204. PubMed ID: 2915514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.
    Velasquez MT; Striffler JS; Abraham AA; Michaelis OE; Scalbert E; Thibault N
    Hypertension; 1997 Nov; 30(5):1232-7. PubMed ID: 9369281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology.
    Thaiss F; Haas C; Helmchen U; Wenzel U; Stahl RA
    Nephrol Dial Transplant; 1996 Jan; 11(1):40-6. PubMed ID: 8649651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
    Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
    Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.
    Zoja C; Corna D; Camozzi D; Cattaneo D; Rottoli D; Batani C; Zanchi C; Abbate M; Remuzzi G
    J Am Soc Nephrol; 2002 Dec; 13(12):2898-908. PubMed ID: 12444208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
    Sebeková K; Lill M; Boor P; Heidland A; Amann K
    Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
    Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
    Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal functional reserve in experimental chronic glomerulonephritis.
    De Nicola L; Peterson OW; Obagi S; Kaiser JA; Wilson CB; Gabbai FB
    Nephrol Dial Transplant; 1994; 9(10):1383-9. PubMed ID: 7816249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Means for the inhibition of the nonimmune progression of nephritis].
    Tareeva IE; Kutyrina IM; Neverov NI
    Klin Med (Mosk); 1995; 73(3):80-3. PubMed ID: 8577123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S239-41. PubMed ID: 3033177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
    Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
    J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.